Eagle Pharmaceuticals, Inc. Current Portion of Long-Term Debt
Eagle Pharmaceuticals, Inc. had Current Portion of Long-Term Debt of $8.30 million as of 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LongTermDebtCurrent · last filed 2023-08-09
- 2023-06-30: Long-term Debt, Current Maturities $8.30M.
- 2023-03-31: Long-term Debt, Current Maturities $7.50M.
- 2022-12-31: Long-term Debt, Current Maturities $6.25M.
- 2022-09-30: Long-term Debt, Current Maturities $34.96M.
| Period end | Long-term Debt, Current Maturities | Long-term Debt, Current Maturities as first filed |
|---|---|---|
| 2023-06-30 | $8.30M 10-Q/A · filed 2023-08-09 | |
| 2023-03-31 | $7.50M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $6.25M 10-Q/A · filed 2023-08-09 | |
| 2022-09-30 | $34.96M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $21.84M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $23.73M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $25.61M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $8.00M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $8.00M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $8.00M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $8.00M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $8.00M 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $7.00M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $116.00M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $5.00M 10-K · filed 2021-03-05 | |
| 2019-09-30 | $5.00M 10-K · filed 2020-03-02 | $4.00M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $5.00M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $5.00M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $6.25M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $5.00M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $6.25M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $6.25M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $4.88M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $5.00M 10-Q · filed 2017-11-08 | |
| 2016-12-31 | $0.00 10-K · filed 2018-02-26 |